Thirumalai Chemicals reports wider consolidated loss in FY26
Thirumalai Chemicals Limited reported a wider consolidated net loss of ₹16,791 lakhs for FY26 compared to ₹4,610 lakhs in the previous year, with a standalone net loss of ₹6,540 lakhs. Q4 consolidated net loss widened to ₹2,800 lakhs from ₹1,406 lakhs, while revenue fell to ₹4,242 lakhs. The company recorded exceptional impairment losses of ₹798 lakhs. Despite negative operating cash flows and net current liabilities, management affirmed the going concern status based on future plans and working capital facilities.

*this image is generated using AI for illustrative purposes only.
Thirumalai Chemicals Limited reported a consolidated net loss of ₹16,791 lakhs for the financial year ended March 31, 2026, compared to a net loss of ₹4,610 lakhs in the previous year. The standalone net loss for FY26 stood at ₹6,540 lakhs. On a quarterly basis, the consolidated net loss for Q4 widened to ₹2,800 lakhs from a loss of ₹1,406 lakhs in the same period last year. Q4 consolidated revenue stood at ₹4,242 lakhs, compared to ₹5,230 lakhs in the corresponding quarter of the previous year. The Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026, at meetings held on May 29 and May 30, 2026.
Financial Performance
The company reported an exceptional item of ₹798 lakhs in the consolidated results for the year ended March 31, 2026, relating to an impairment loss of non-operational plants. This includes an impairment loss of ₹354 lakhs pertaining to a subsidiary plant located in Malaysia. The standalone financial results recognized an impairment loss of ₹444 lakhs. The following table summarizes the key financial metrics for FY26:
| Particulars | Standalone FY26 (₹ in lakhs) | Consolidated FY26 (₹ in lakhs) |
|---|---|---|
| Revenue from operations | 1,35,973 | 1,73,552 |
| Total Income | 1,39,328 | 1,75,423 |
| Total Expenses | 1,48,349 | 1,94,804 |
| Net Loss for the year | (6,540) | (16,791) |
The quarterly performance reflects a continued year-on-year decline, with Q4 consolidated revenue falling to ₹4,242 lakhs from ₹5,230 lakhs, while the consolidated net loss deepened to ₹2,800 lakhs compared to a loss of ₹1,406 lakhs in the year-ago quarter.
| Metric | Q4 FY26 | Q4 FY25 |
|---|---|---|
| Consolidated Net Loss | ₹2,800 lakhs | ₹1,406 lakhs |
| Consolidated Revenue | ₹4,242 lakhs | ₹5,230 lakhs |
Liquidity and Going Concern
The Holding Company reported negative operating cash flows of ₹20,562 lakhs for FY26. As of March 31, 2026, current liabilities exceeded current assets (excluding loans from subsidiaries) by ₹21,153 lakhs. However, including loans from subsidiaries, current assets exceeded current liabilities by ₹13,562 lakhs. The management stated that based on cash flow projections, future business plans, and the revolving nature of working capital facilities, the company is prepared on a going concern basis.
The Group reported negative operating cash flows of ₹13,073 lakhs for the year. Net current liabilities were primarily attributable to capital expenditure by TCL Specialties LLC, USA. The subsidiary has received a communication from a prospective lender expressing an intention to undertake diligence for a proposed first lien senior secured term loan facility of up to USD 130 million.
Historical Stock Returns for Thirumalai Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.69% | +2.26% | -16.00% | -28.14% | -42.53% | +26.09% |
What is the likelihood of TCL Specialties LLC securing the proposed USD 130 million loan, and how will its approval impact the group's liquidity position?
How does the company plan to reverse the year-on-year revenue decline and address the widening net losses in the upcoming fiscal year?
Will the impairment of non-operational plants lead to further restructuring or asset sales to streamline operations?


































